Women’s Health & OB/GYN News

The FDA issued a warning that use of fezolinetant, a nonhormonal medication indicated for treating menopausal hot flashes, can cause rare but serious liver injury, according to an agency press release.

CHICAGO — The benefits of AI-assisted technology in medicine are rapidly extending to obstetrics and gynecology, with programs in development or already deployed to predict everything from mode of delivery during labor to cervical cancer risk.

CHICAGO — In this Healio video exclusive, Pauline M. Maki, PhD, provides three takeaways from her talk on cognition and hormone therapy during menopause at the Annual Meeting of The Menopause Society.

CHICAGO — Nonhormonal elinzanetant was associated with fewer moderate to severe vasomotor symptoms compared with placebo for up to 1 year, along with similar long-term positive safety data, researchers reported.

CHICAGO — Voice and respiratory changes can impact women’s health during menopause and hormone therapy plays a role in helping or worsening these changes, according to a speaker at the Annual Meeting of The Menopause Society.

Tubal sterilization rates in women rose in the U.S. after the Supreme Court’s 2022 decision in Dobbs v. Jackson Women’s Health Organization, results from research letter published in JAMA revealed.

Professional fulfillment can be achieved through a culture of wellness, efficiency of practice in the workplace and personal resilience, according to a speaker at the Ending Clinician Burnout Global Summit.

The FDA announced it has commissioned an independent literature review and internal bench laboratory study to evaluate metals in tampons after a recent study suggested tampons sold in the U.S. tested for the presence of toxic metals.

CHICAGO — Hormone therapy is beneficial for some women beyond age 65 years to treat ongoing menopausal symptoms that affect their quality of life, according to research reported at the Annual Meeting of The Menopause Society.

CHICAGO — Exposure to trauma was tied to increased measures of inflammation and neuronal death for Black women and accelerated brain age indicators regardless of race and ethnicity, researchers reported.